Relay Therapeutics RLAY
NASDAQ RLAY
$18.97 -0.04 (-0.21%)
As of: Sep 4, 2026 · 1:35 PM EDT

Relay Therapeutics (RLAY) FCF Margin (QoQ) (2021 - 2026)

Analysis

Relay Therapeutics (RLAY) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Relay Therapeutics 3.85 Bn 3.85 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.38 Mn
Mar 31, 2026 -106,279.00
Jun 30, 2025 -720,809.00
Mar 31, 2024 -893.11 Mn
Dec 31, 2023 893.09 Mn
Sep 30, 2023 5.86 Mn
Jun 30, 2023 -2.84 Mn
Mar 31, 2023 -707,460.00
Dec 31, 2022 -363,908.00
Sep 30, 2022 -368,652.00
Jun 30, 2022 -374,806.00
Mar 31, 2022 -524,442.00
Dec 31, 2021 105,696.00
Sep 30, 2021 -480,983.00
Jun 30, 2021 -825,449.00